Crinetics Pharmaceuticals, Inc. (CRNX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$37.75
Day's range
$39.25

Crinetics Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 15.84 M $592.74 M   0.51% 15.22%
BLACKROCK, INC. 08/07/2026 9.76 M $365.18 M   15.10% 9.37%
FARALLON CAPITAL MANAGEMENT LLC 08/14/2026 8.99 M $336.37 M   7.81% 8.64%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 7.13 M $266.85 M   -12.58% 6.85%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 6.46 M $241.87 M   1.06% 6.21%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 6.21 M $232.48 M   16.01% 5.97%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 4.83 M $180.84 M   4.18% 4.64%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 4.75 M $177.57 M   1.53% 4.56%
JUPITER TOPCO LLC 08/14/2026 4.56 M $170.51 M   100.00% 4.38%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.73 M $102.09 M   9.95% 2.62%
STATE STREET CORP 08/07/2026 2.69 M $100.64 M   11.91% 2.58%
BELLEVUE GROUP AG 08/14/2026 2.62 M $98.04 M   -20.12% 2.52%
BAKER BROS. ADVISORS LP 08/14/2026 2.35 M $87.99 M   0.00% 2.26%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 2.27 M $85.11 M   100.00% 2.18%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 2.08 M $77.57 M   10.14% 1.99%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 2.01 M $75.23 M   3.59% 1.93%
GW&K INVESTMENT MANAGEMENT, LLC 08/12/2026 1.73 M $64.78 M   6.95% 1.66%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 08/13/2026 1.68 M $62.81 M   -2.21% 1.61%
SIREN, L.L.C. 08/13/2026 1.42 M $53.17 M   -25.36% 1.36%
JPMORGAN CHASE & CO 08/12/2026 1.37 M $50.60 M   3.05% 1.31%
FIRST LIGHT ASSET MANAGEMENT, LLC 08/14/2026 1.36 M $50.92 M   24.89% 1.31%
MORGAN STANLEY 08/13/2026 1.34 M $50.09 M   45.54% 1.29%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.33 M $49.88 M   86.15% 1.28%
NOVO HOLDINGS A/S 08/14/2026 1.32 M $49.39 M   -14.84% 1.27%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.27 M $47.54 M   49.08% 1.22%
AMERICAN CENTURY COMPANIES INC 08/12/2026 1.26 M $47.25 M   19.92% 1.21%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 1.22 M $45.73 M   7.26% 1.17%
SUVRETTA CAPITAL MANAGEMENT, LLC 08/14/2026 1.19 M $44.39 M   13.64% 1.14%
MARSHALL WACE, LLP 08/13/2026 1.13 M $42.16 M   64.69% 1.08%
GOLDMAN SACHS GROUP INC 08/14/2026 1.10 M $41.35 M   75.91% 1.06%
ORBIMED ADVISORS LLC 08/14/2026 999.00 K $37.38 M   0.00% 0.96%
NORTHERN TRUST CORP 08/13/2026 974.78 K $36.48 M   15.87% 0.94%
HOOD RIVER CAPITAL MANAGEMENT LLC 08/14/2026 969.00 K $36.26 M   6.79% 0.93%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 877.64 K $32.84 M   5.31% 0.84%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 877.64 K $32.84 M   100.00% 0.84%
ABRDN PLC 07/31/2026 820.40 K $30.70 M   0.00% 0.79%
CANDRIAM S.C.A. 08/13/2026 819.03 K $30.62 M   -1.44% 0.79%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 754.44 K $28.23 M   6.49% 0.72%
FISHER ASSET MANAGEMENT, LLC 08/04/2026 741.55 K $27.75 M   -2.77% 0.71%
UBS GROUP AG 08/13/2026 561.17 K $21.00 M   -1.88% 0.54%
NUVEEN, LLC 08/11/2026 555.38 K $20.78 M   0.71% 0.53%
AMERIPRISE FINANCIAL INC 08/14/2026 497.21 K $18.61 M   -37.72% 0.48%
SCHRODER INVESTMENT MANAGEMENT GROUP 08/13/2026 480.50 K $17.75 M   25.67% 0.46%
IMPAX ASSET MANAGEMENT GROUP PLC 08/11/2026 435.00 K $16.28 M   24.29% 0.42%
BANK OF NEW YORK MELLON CORP 08/06/2026 393.69 K $14.73 M   9.75% 0.38%
PROSIGHT MANAGEMENT, LP 08/14/2026 374.67 K $14.02 M   7.05% 0.36%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 08/06/2026 373.91 K $13.99 M   -12.15% 0.36%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 365.71 K $13.69 M   100.00% 0.35%
BRAUN STACEY ASSOCIATES INC 08/05/2026 348.14 K $13.03 M   7.18% 0.33%
FIERA CAPITAL CORP 08/07/2026 338.84 K $12.68 M   -42.54% 0.33%

Crinetics Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 345 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals Inc. The most heavily invested institutionals were:

FMR LLC: 15.84 M

BlackRock, Inc.: 9.76 M

FARALLON CAPITAL MANAGEMENT LLC: 8.99 M

WELLINGTON MANAGEMENT GROUP LLP: 7.13 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 6.46 M

PRICE T ROWE ASSOCIATES INC /MD/: 6.21 M

119.53% of Crinetics Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 146.00 M shares in the last 24 months. This purchase volume represents approximately $5.58 B in transactions.